Megan I. Samuelson
Director
Surgeical Pathology
University of Iowa Health care
France
Biography
Education BA, Biology, Grinnell College MD, University of Iowa Carver College of Medicine Extern, University of Iowa Hospitals and Clinics Resident, Pathology, University of Iowa Hospitals and Clinics Fellow, Surgical Pathology, University of Iowa Hospitals and Clinics Fellow, Cytopathology, University of Iowa Hospitals and Clinics Licensure and Certifications Cytopathology - American Board of Pathology Anatomic and Clinical Pathology - American Board of Pathology
Research Interest
Infectious Diseases
Publications
-
Girardi, J. R., Samuelson, M., Button, A., De Geest, K., Bender, D. P., Ahmed, A. & Goodheart, M. J. (2011). The relationship between vascularity, p53 gene mutations and distant metastatic disease in epithelial ovarian carcinoma. (Vols. 123). (2), pp. 443. Gynecol Oncol.
-
Nadkarni, N., Rogers, L., Samuelson, M., Neff, T., Bender, D. P., Ahmed, A., De Geest, K., Button, A., Dupuy, A. & Goodheart, M. J. (2011). Zmiz1 is overexpressed in epithelial ovarian cancer and associated with p53 gene mutations. (Vols. 123). (2), pp. 446-447. Gynecologic Oncology.
-
Bender, D., Sill, M. W., Lankes, H. A., Reyes, H. D., Darus, C. J., Delmore, J. E., Rotmensch, J., Gray, H. J., Mannel, R. S., Schilder, J. M., Hunter, M. I., McCourt, C. K., Samuelson, M. & Leslie, K. K. (2015). A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol, 138(3), 507-512. PMID: 26186911.
